Nutranomics Inc
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing Sy… Read more
Nutranomics Inc (NNRX) - Net Assets
Latest net assets as of April 2023: $-14.08 Million USD
Based on the latest financial reports, Nutranomics Inc (NNRX) has net assets worth $-14.08 Million USD as of April 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($17.81 Million) and total liabilities ($31.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-14.08 Million |
| % of Total Assets | -79.09% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3792.55 |
Nutranomics Inc - Net Assets Trend (2008–2022)
This chart illustrates how Nutranomics Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nutranomics Inc (2008–2022)
The table below shows the annual net assets of Nutranomics Inc from 2008 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-07-31 | $-10.55 Million | -277.57% |
| 2021-07-31 | $-2.79 Million | +60.40% |
| 2020-07-31 | $-7.06 Million | -10.97% |
| 2019-07-31 | $-6.36 Million | -336.91% |
| 2015-07-31 | $-1.46 Million | -6.37% |
| 2014-07-31 | $-1.37 Million | -7713.74% |
| 2013-07-31 | $17.98K | +114.68% |
| 2012-07-31 | $-122.42K | -330.16% |
| 2011-07-31 | $-28.46K | -333.02% |
| 2009-07-31 | $-6.57K | -128.63% |
| 2008-07-31 | $22.95K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nutranomics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 947141300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.40 Million | % |
| Other Comprehensive Income | $-1.40 Million | % |
| Total Equity | $-10.55 Million | 100.00% |
Nutranomics Inc Competitors by Market Cap
The table below lists competitors of Nutranomics Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
My Foodie BOX Ltd
AU:MBX
|
$418.97K |
|
SeAH Besteel Corp.
KQ:001430
|
$419.04K |
|
BERKELEY GRP - Dusseldorf Stock Exchang
DU:42BA
|
$419.07K |
|
POWER CORP CDA SV
BE:PCR
|
$419.33K |
|
KURITA WATER IND - Dusseldorf Stock Exchang
DU:KWI
|
$418.93K |
|
NEWGOLD
XBOT:NEWG-ETF
|
$418.89K |
|
EvokAI Creative Labs Inc
OTCQB:OKAIF
|
$418.45K |
|
ValueInvest Global Akk KL
CO:VAIGAKA
|
$418.38K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nutranomics Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -2,794,829 to -10,552,391, a change of -7,757,562.
- Net loss of 6,629,775 reduced equity.
- Other comprehensive income decreased equity by 1,402,378.
- Other factors increased equity by 274,591.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.63 Million | -62.83% |
| Other Comprehensive Income | $-1.40 Million | -13.29% |
| Other Changes | $274.59K | +2.6% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Nutranomics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-07-31 | $0.00 | $0.00 | x |
| 2009-07-31 | $0.00 | $0.00 | x |
| 2011-07-31 | $0.00 | $0.00 | x |
| 2013-07-31 | $0.00 | $0.00 | x |
| 2014-07-31 | $-0.03 | $0.00 | x |
| 2015-07-31 | $-0.01 | $0.00 | x |
| 2019-07-31 | $0.00 | $0.00 | x |
| 2020-07-31 | $0.00 | $0.00 | x |
| 2021-07-31 | $0.00 | $0.00 | x |
| 2022-07-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nutranomics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -232.89%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-21.10%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -100.95% | 0.00% | 0.00x | 1.37x | $-25.47K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-38.47K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.40K |
| 2012 | 0.00% | 2.08% | 5.51x | 0.00x | $73.15K |
| 2013 | -131.11% | -0.82% | 46.11x | 3.45x | $-25.36K |
| 2014 | 0.00% | -90.41% | 4.37x | 0.00x | $-2.04 Million |
| 2015 | 0.00% | -68.04% | 3.99x | 0.00x | $-1.07 Million |
| 2019 | 0.00% | -3759.32% | 2.02x | 0.00x | $-1.60 Million |
| 2020 | 0.00% | -109161.31% | 0.03x | 0.00x | $-244.98K |
| 2021 | 0.00% | -107.50% | 0.11x | 0.00x | $-1.61 Million |
| 2022 | 0.00% | -232.89% | 0.16x | 0.00x | $-5.57 Million |
Industry Comparison
This section compares Nutranomics Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nutranomics Inc (NNRX) | $-14.08 Million | -100.95% | N/A | $418.94K |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |